Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €0.36 EUR
Change Today +0.0031 / 0.87%
Volume 333.4K
MLM On Other Exchanges
Symbol
Exchange
Frankfurt
As of 11:30 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - MOLECULAR MEDICINE SPA (MLM)

MolMed S.p.A. to Report Q3, 2015 on Nov 09, 2015
CapIQ 11/09/2015 5:00 AM ET
MolMed S.p.A. to Report First Half, 2015 on Aug 03, 2015
CapIQ 11/09/2015 5:00 AM ET
MolMed S.p.A. to Report Q1, 2015 on May 11, 2015
CapIQ 11/09/2015 5:00 AM ET

2013 revenues at MolMed S.p.A. totaled €6.7M EUR, while annual losses equaled €0.08 per share.

Quarterly Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)

Chart not available

MolMed S.p.A.'s Quarterly Earnings

MolMed S.p.A. reported 2nd quarter 2014 losses of €0.02 per share on 08/4/2014.

Annual Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)

Chart not available

MolMed S.p.A.'s Annual Earnings

MolMed S.p.A. reported annual 2013 losses of €0.08 per share on 03/5/2014.

Quarterly Revenues - MOLECULAR MEDICINE SPA (MLM)

Chart not available

MolMed S.p.A.'s Quarterly Revenues

MolMed S.p.A. had 2nd quarter 2014 revenues of €3.3M EUR. This bettered the €1.8M EUR estimate of the one analyst covering the company. This was 132.4% above the prior year's 2nd quarter results.

Annual Revenues - MOLECULAR MEDICINE SPA (MLM)

Actuals vs. Estimates for MOLECULAR MEDICINE SPA MLM

MolMed S.p.A.'s Annual Revenues

MolMed S.p.A. had revenues for the full year 2013 of €6.7M EUR. This was 32.7% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLM:IM €0.36 EUR +0.0031

MLM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLM.
View Industry Companies
 

Industry Analysis

MLM

Industry Average

Valuation MLM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.2x
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOLECULAR MEDICINE SPA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.